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Abstract 
Hope is a trait that represents the capacity to identify strategies or pathways to achieve goals and 
the motivation or agency to effectively pursue those pathways. Hope has been demonstrated to 
be a robust source of resilience to anxiety and stress and there is limited evidence that, as has 
been suggested for decades, hope may function as a core process or transdiagnostic mechanism 
of change in psychotherapy. The current study examined the role of hope in predicting recovery 
in a clinical trial in which 223 individuals with 1 of 4 anxiety disorders were randomized to 
transdiagnostic cognitive behavior therapy (CBT), disorder-specific CBT, or a waitlist controlled 
condition. Effect size results indicated moderate to large intraindividual increases in hope, that 
changes in hope were consistent across the five CBT treatment protocols, that changes in hope 
were significantly greater in CBT relative to waitlist, and that changes in hope began early in 
treatment. Results of growth curve analyses indicated that CBT was a robust predictor of 
trajectories of change in hope compared to waitlist, and that changes in hope predicted changes 
in both self-reported and clinician-rated anxiety. Finally, a statistically significant indirect effect 
was found indicating that the effects of treatment on changes in anxiety were mediated by 
treatment effects on hope. Together, these results suggest that hope may be a promising 
transdiagnostic mechanism of change that is relevant across anxiety disorders and treatment 
protocols.  
 
 
Keywords: Hope; CBT; Anxiety; Mechanism of Change; Transdiagnostic  
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Hope is a Transdiagnostic Mechanism of Change across Anxiety Disorders and CBT Treatment 
Protocols 
Remarkable progress has been made in developing evidence-based treatments for anxiety 
disorders in recent decades (Barlow, 2014). Cognitive behavioral treatment (CBT) protocols now 
exist for each of the anxiety disorders that have been shown to be generally efficacious in 
promoting symptom recovery. One of the noteworthy aspects of this progress is the evidence 
from psychotherapy research and clinical trials that different forms of CBT often have very 
similar outcomes when compared directly (e.g., Resick et al., 2002). Although considerable 
debate remains about the relative role of common factors versus treatment specific mechanisms, 
there is a clear need to improve our understanding of the causal factors or mechanisms of change 
of empirically-supported treatments (Kazdin, 2007), and to consider whether shifting our focus 
to the core competencies and transdiagnostic processes of CBT may be a more effective long-
term strategy for improving CBT treatments (Hayes & Hofmann, 2018). The present study 
focuses on the role of hope as a potential core component or transdiagnostic mechanism of 
change in CBT treatments for anxiety disorders. 
Defining Hope 
 The most widely studied model of hope presupposes that human behavior is motivated by 
the identification and pursuit of goals, and defines hope as the interaction of pathways thinking, 
or the capacity to identify strategies to pursue one’s goals, and agency thinking, or the 
motivation to effectively pursue one’s pathways to achieve goals (Snyder, 2002). These 
components are complementary and bidirectional, alternately boosting motivation and promoting 
goal-directed behavior. For example, having hope in one’s ability to solve problems helps one 
persevere when confronted with obstacles and stressful situations (Snyder, 2002). Snyder’s 
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model frames hope as a cognitive process, emphasizing the role of positive expectations while 
pursuing goals. 
 Hope is closely related to other positive psychology constructs such as self-efficacy and 
optimism that have also been shown to have clear relevance to promoting resilience to and 
recovery from emotional disorders. There are important conceptual and empirical differences 
between these constructs, however, that provide clear evidence that hope may uniquely influence 
anxiety disorders and related outcomes. Bandura (1997) defines self-efficacy as the perceived 
ability to perform the necessary behaviors to achieve a desired outcome. However, Bandura’s 
theory does not concern the ability to generate pathways towards one’s goals, and places less 
emphasis on one’s motivation to enact the behaviors required to achieve them (Rand, 2018). 
Optimism, on the other hand, is a general positive expectancy that good things will happen in the 
future (Scheier & Carver, 1985). While optimism is also a type of positive expectancy, it does 
not focus on the individual’s perceived intention or capacity to bring about the future good. 
Studies using confirmatory factor analysis have demonstrated that although hope, optimism, and 
self-efficacy are moderately to highly correlated, they are distinct constructs (Magaletta & 
Oliver, 1999). Therefore, while there is evidence of self-efficacy as potential mechanism of 
change of CBT for anxiety disorders (e.g., Gallagher et al., 2013), it is important to demonstrate 
the specific role that hope may have in promoting recovery during CBT.   
 Hope is also relevant to widely examined cognitive constructs in the anxiety disorders 
realm that are related to vulnerability to or recovery from emotional disorders. For example, 
perceived control in relation to negative emotions and negative events has been proposed to be a 
transdiagnostic vulnerability factor that plays an important role in the development of the anxiety 
disorders (Barlow, 2002). Meta-analytic reviews have supported this theory and have shown that 
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deficits in perceived control are a robust predictor of higher symptoms of multiple anxiety 
disorders (Gallagher, Bentley, & Barlow, 2014) and changes in perceived control following CBT 
treatment predict the longitudinal course of anxiety symptoms across diagnostic boundaries 
(Gallagher, Naragon-Gainey, & Brown, 2014). There is limited empirical evidence regarding the 
link between hope and perceived control, but conceptually perceived control differs from hope in 
that perceived control focuses on domain specific evaluations of the potential capacity to control 
negative emotions/experiences rather than global evaluations of one’s capacity and likelihood to 
do what is necessary to achieve one’s goals, and perceived control does not capture the strategies 
or pathways by which coping may occur, as does hope.  
 Treatment outcome expectancy is another cognitive process that is conceptually relevant 
to hope and has been widely examined in relation to treatment outcome for anxiety disorders. 
Many studies have examined expectancy beliefs during CBT for anxiety disorders and found 
expectancy to be an important predictor of both treatment process and outcomes (e.g., 
Constantino, Visla, Coyne & Boswell, 2018). Commonly measured using the credibility and 
expectancy questionnaire (CEQ; Devilly & Borkovec, 2000), expectancy captures more global 
positive expectancies regarding treatment and is assessed using items such as “How much do you 
really feel that therapy will help you to reduce your symptoms”. Expectancy as traditionally 
examined in CBT trials is therefore more similar conceptually to optimism than hope as it 
focuses on generalized positive expectancies rather pathways cognitions or personal agency. 
There is some evidence from other contexts that hope and expectancy beliefs have a weak, 
positive correlation (Haanstra, Tilbury, Kamper, Tordoir Vliet Vlieland et al., 2015), but 
outcome expectancy beliefs have been more widely examined in past work than the more general 
construct of hope (Halperin, Weitzman, & Otto, 2010). Thus, while hope is linked to cognitive 
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constructs that are commonly examined in the CBT treatment outcome literature, hope is 
conceptually and empirically distinct from these constructs. 
Hope and Mental Health 
Decades of research have now demonstrated that hope is broadly relevant to positive 
mental health and many forms of psychopathology (Gallagher & Lopez, 2018; Ritschel & 
Sheppard, 2018; Snyder, 2002). Those high in hope tend to experience positive emotions during 
goal pursuit and are more motivated to persist in the face of obstacles (Snyder, 2002). Hope is a 
robust predictor of various facets of positive mental health even when controlling for related 
constructs such as optimism (Gallagher & Lopez, 2009). Higher levels of hope are also a robust 
predictor of negative affect and psychopathology, with meta-analytic reviews demonstrating the 
robust associations across many studies (Alarcon, Bowling, & Khazon, 2013). In particular, hope 
appears to be associated with lower levels of anxiety and stress disorders (Long & Gallagher, 
2018; Arnau, 2018), and there is evidence that hope prospectively predicts lower levels of 
anxiety even when controlling for previous levels of anxiety (Arnau et al., 2007). 
There is also increasing evidence regarding the mechanisms by which hope may promote 
higher levels of mental health and lower levels of anxiety and related disorders, and why, 
therefore, promoting hope during treatment may, in turn, promote recovery during CBT for 
anxiety disorders. Individuals high in hope tend to perceive obstacles as less stressful, are 
quicker to rebound from obstacles, and demonstrate resilience in response to challenging 
circumstances (Snyder, 2002). Hope is associated with adaptive coping styles such as problem-
focused coping and active coping, and is inversely related to maladaptive coping styles such as 
denial and distancing (e.g., Hassija, Luterek, Naragon-Gainey, Moore, & Simpson, 2012). 
Therefore, one way hope may contribute to recovery during CBT is by serving as a positive trait 
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that provides a foundation for facilitating effective coping, regardless of the specific diagnosis 
being treated.   
Hope in Psychotherapy 
Beyond the recent evidence regarding the mental health benefits of hope, there is a long 
tradition of suggesting hope as a psychological resource that may be broadly relevant in 
psychotherapy (Frank, 1968; Frank & Frank; 1993). It is proposed that a consistent element of all 
effective psychosocial treatments may be the reestablishment and promotion of hope, and 
although hope should not be considered the sole factor in promoting recovery during 
psychotherapy, the instillation of hope in psychotherapy may be a mechanism that facilitates 
recovery across diagnoses and across different psychotherapy modalities, including those that do 
not explicitly target hope (Snyder et al., 2000; Snyder, Ilardi, Michael, & Cheavens 2000). As a 
core process or mechanism of treatment, hope can engender motivation, promote healthy coping, 
and aid in pursuit of goals in the context of psychotherapy (Snyder, Ilardi, Cheavens, Michael, 
Yamhure, & Sympson, 2000).   
Although evidence suggests that hope is a generally stable trait (Marques & Gallagher, 
2017), there is increasing evidence that hope is malleable and that targeted brief interventions 
can lead to increases in hope (Feldman & Dreher, 2012) and that psychotherapy can also result in 
meaningful increases in hope. Interventions developed to specifically target hope have been 
shown to lead to significant increases in hope as well as improvements in depression, anxiety and 
meaning in life (Cheavens, Feldman, Gum, Michael & Snyder, 2006). There is also evidence that 
interventions for stress and anxiety disorders that do not specifically target hope can produce 
substantial intraindividual changes in hope (Gilman et al., 2012) and that hope is an important 
predictor both at the early stages of treatment as well as functioning during later stages of 
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psychotherapy (Irving et al., 2004).  
Hope in CBT 
Hope may be especially relevant within CBT, because it is problem-focused and involves 
forming specific goals and strategies (i.e., pathways) to more effectively cope with symptoms of 
anxiety and depression, and motivating clients to pursue them (agency; Beck, 2011).  Prior to 
entering therapy, clients may be relatively demoralized and lacking in motivation because they 
have not been able to address their problems with their current coping skills (Frank & Frank, 
1991; Snyder et al., 2000; Cheavens, Feldman, Woodward & Snyder, 2006).  However, clients 
begin to demonstrate agency by initiating treatment, which represents a viable pathway towards 
ameliorating their symptoms.  When presented with a convincing treatment rationale, client’s 
hopeful thinking will then be reinforced.  During this remoralization stage of therapy, they will 
develop positive expectations about the course and outcomes of treatment as well as the agency 
to make changes in their lives (Irving et al., 2004).   
In order to address the client presenting problems, CBT involves setting relevant and 
attainable goals, which maximally engender hope (Snyder et al., 2000).  CBT therapists help 
clients generate pathways towards their goals and break them down into manageable steps.  
Within the context of emotional disorders, for example, treatment via exposure can be thought of 
as a CBT-specific pathway towards the goal of symptom reduction (Snyder, et al., 2000; 
Cheavens et al., 2006).  The process of habituation and building tolerance of engaging with 
feared situations or stimuli while progressing through the exposure hierarchy sustains agency and 
pathways thinking, which should generalize outside of treatment.  During the termination phase 
of therapy, reviewing treatment gains of therapy reinforces agency, and considering ways to 
address future obstacles, a common component of relapse prevention, builds pathways thinking 
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(Cheavens et al., 2006). The skills that clients build to cope with strong emotions within the 
context of CBT should generalize to other areas of their lives after termination, thereby 
preventing relapse (Snyder et al., 2000). 
Evidence of Hope as a Mechanism of Recovery During CBT 
If hope operates as a consistent mechanism of recovery, the benefits of bolstering hope 
should be broadly applicable across CBTs for different emotional disorders and forms of 
psychopathology (Gallagher, 2017). Preliminary evidence provides some support for the role of 
hope as a mechanism of change within the context of CBT.  Within the context of Cognitive 
Processing Therapy, considered one of the “gold standard” CBT treatments for PTSD, levels of 
hope at midtreatment were associated with decreases in PTSD symptoms (Gilman et al., 2012).  
In addition, people who experienced sudden gains during treatment tended to have had greater 
hope-related cognitions during the preceding session within the context of exposure-based 
cognitive therapy for depression (Hayes et al., 2007).  A study by Irving et al. (2004) found that 
higher baseline hope after completing a 5-week pre-therapy orientation group (designed to 
identify goals and bolster pathways and agency) was associated with improvements in symptoms 
and functioning throughout the course of subsequent treatment for clients with primary 
emotional disorder diagnoses.  Furthermore, increases in agency were associated with improved 
functioning midway through therapy, while increased pathways were associated with greater 
subjective well-being prior to termination. Evidence to date, therefore, suggests that CBT does, 
in fact, promote hope (and decrease the related construct of hopelessness; e.g., Gallagher & 
Resick, 2012) and that these changes are associated with symptom improvement.  
Unresolved Questions 
Despite the compelling theoretical case for the potential role of hope as a transdiagnostic 
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mechanism or core process in CBT and the promising evidence reviewed, there are important 
limitations in the current evidence regarding the role of hope as a mechanism of CBT. 
Specifically, there is limited data directly comparing the impact of treatment protocols on hope. 
If hope is truly a core element of CBT, then the effect size magnitude of increases in hope during 
different treatments and in the treatment of different diagnoses should be generally consistent. 
There is also limited evidence regarding the timing of when changes in hope occur during 
treatment. The demonstration of temporal precedence of change is a crucial factor in identifying 
mechanisms of change (Kazdin, 2007), but we have limited evidence that hope changes early in 
treatment, which would be one step in concluding that hope may be a causal mechanism of 
recovery during treatment. Finally, there is limited evidence regarding how trajectories of hope 
during treatment predict symptom trajectories, which limits our understanding of the degree to 
which changes in hope relate to recovery during treatment. Demonstrating that different forms of 
CBT consistently promote hope and that hope consistently predicts symptom recovery would 
support the decades-long contention that instilling hope may be an important core process of 
efficacious treatments for anxiety disorders. 
Study Aims 
 The goals of the present study were to 1) quantify the magnitude and timing of the impact 
of CBT on hope, 2) examine the extent to which changes in hope during CBT were consistent 
across principal diagnosis and treatment protocol, and 3) examine the extent to which 
intraindividual changes in hope predicted changes in self-reported and clinician-rated anxiety 
outcomes. Our hypotheses were that CBT would result in moderate to large increases in hope, 
that the increases in hope would be consistent across treatments and protocols, and that changes 
in hope would not only predict changes in anxiety, but would also partially temporally precede 
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changes in anxiety. These hypotheses were examined using data from a recently published 
clinical trial that compared active CBT protocols and a wait list condition (Barlow, Farchione, 
Bullis, Gallagher, Murray-Latin et al., 2017). 
Method 
Participants 
 Participants were 223 adults (55.6% female) who sought treatment at a large outpatient 
clinic in Boston, MA. The age of participants ranged from 18 to 66 years with a mean of 31.1 
(SD = 11.0). The majority of participants identified as Caucasian (83.4%), not currently married 
(78.9%), and with a college degree or higher (66.8%). In order to be eligible for the trial, 
participants had to receive a principal diagnosis of panic disorder with or without agoraphobia 
(PDA; 26.5%), generalized anxiety disorder (GAD; 27.8%), social anxiety disorder (SOC; 
26.0%), or obsessive-compulsive disorder (19.7%). A large majority (84.3%) of participants met 
criteria for at least 1 comorbid diagnosis, with an average of 2.3 (SD = 1.8) comorbid diagnoses. 
Experimental Design and Conditions 
 See Barlow et al. (2017) for more complete details about the study design and conditions. 
Participants were randomized based on their principal diagnosis to receive transdiagnostic CBT, 
disorder specific CBT, or a waitlist controlled condition using block randomization and a 2:2:1 
allocation ratio. Transdiagnostic CBT consisted of the Unified Protocol (Barlow et al., 2017), a 
recently developed modular CBT protocol that was designed to be used across anxiety and mood 
disorders. Disorder specific CBT protocols were selected as gold-standard treatments, such that 
each had demonstrated efficacy for the respective diagnosis and included: Managing Social 
Anxiety: A Cognitive-Behavioral Therapy Approach, (MSA; Hope, Heimberg & Turk, 2010), 
Mastery of Your Anxiety and Worry, second edition (MAW; Craske and Barlow, 2006), Mastery 
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of Your Anxiety and Panic, fourth edition (MAP; Barlow and Craske, 2006), and Treating Your 
Obsessive- Compulsive Disorder With Exposure and Response (Ritual) Prevention Therapy, 
second edition (MOCD; Foa, Yadin, and Lichner, 2012). In all conditions, outcomes were 
assessed at baseline, session 4, session 8, session 12, and session 16. Participants with a principal 
diagnosis of panic disorder received a 12 week course of treatment as specified in the MAP 
protocol, but completed an additional assessment four weeks post-treatment to provide outcome 
data at the same time as session 16 for participants in other conditions and to facilitate 
comparisons across diagnoses/treatments. A six month follow-up assessment was completed by 
participants in the active treatment conditions. 
Measures 
 Hope. The State Hope Scale (SHS; Snyder, Sympson, Ybasco, Borders, Babyak, & 
Higgins, 1996) was used to assess changes in hope during the course of treatment. The SHS 
consists of six items, three that measure agency (e.g., “At the present time, I am energetically 
pursuing my goals” & “At this time, I am meeting the goals that I have set for myself”) and three 
that measure pathways (e.g., “There are lots of ways around any problem that I am facing now” 
& “I can think of many ways to reach my current goals”). The SHS is highly correlated with trait 
measures of hope (Snyder et al., 1996), and was chosen for use in the present study as the SHS 
has previously been demonstrated to be more sensitive to intraindividual changes in hope than 
trait measures, and has previously been used to examine changes in hope during psychotherapy 
(e.g., Cheavens et al., 2006). In the present study, baseline levels of hope (r = .25, p  < .01) and 
session four levels of hope (r  = .28, p < .01) exhibited small to moderate positive correlations 
with expectancy ratings at session 2 as measured by the CEQ. The internal consistency of the 
SHS was high at each assessment (Cronbach’s alphas ranged from .89 to .93). 
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Clinician Rated Anxiety. Clinician rated levels of anxiety were assessed using the 
Hamilton Anxiety Rating Scale (HAMA; Hamilton, 1959). The HAMA is clinician rated 
measure that has been used extensively in clinical trials of CBT for anxiety, and provides an 
overall rating of symptom severity across diagnostic boundaries. The HAMA assessments were 
conducted by independent evaluators who were blind to condition and followed the Structured 
Interview Guide for the Hamilton Anxiety Scale (Shear, Vander Bilt, & Rucci, 2001). 
Self-Reported Anxiety. Self-reported levels of anxiety were assessed using the Overall 
Anxiety Severity and Impairment Scale (Norman, Cissell, Means-Christensen, & Stein, 2006). 
The OASIS is a five item measure that captures both anxiety symptom frequency/severity (e.g. 
“In the past week, when you have felt anxious, how intense or severe was your anxiety”) and the 
associated impairment related to anxiety symptoms (e.g., “In the past week, how much did your 
anxiety interfere with your ability to do the things you needed to do at work, at school, or at 
home?”). The OASIS was designed to provide a brief measure of anxiety that can be used across 
diagnostic boundaries and has been shown to be sensitive to changes in anxiety during CBT 
(e.g., Barlow et al., 2017). The internal consistency of the OASIS was high at each assessment 
(Cronbach’s alphas ranged from .83 to .88). 
Analytic Plan 
 All analyses were conducted using Mplus 8.0 (Muthén & Muthén, 1998 –2016) and 
robust maximum likelihood estimation. Missing data in all models was handled by using 
multiple imputation procedures in which 1000 imputed datasets were calculated using Mplus, 
and then analyses were conducted using the imputed datasets. Changes in hope within treatment 
conditions were first examined by calculating effect sizes (standardized mean gain; ESsg) that 
accounted for the correlations in hope between assessment points. As a preliminary analysis, a 
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series of longitudinal measurement invariance models were examined to ensure that changes in 
hope during treatment represented true changes in hope and not merely changes in the 
measurement of hope across time. These models supported longitudinal measurement invariance 
of hope across time.  
Latent growth curve (LGC) modeling was then used to characterize the overall 
trajectories of change in hope, how changes in hope varied between CBT treatment conditions 
and the waitlist condition, and the extent to which changes in hope mediated the effects of CBT 
treatment on changes in anxiety. For all LGC analyses, shape factors were specified such that the 
slope factor was centered on the baseline assessment, the post-treatment assessment loading was 
fixed at 1.0, and intermediate assessment loadings were freely estimated. The slope factors in the 
LGC models, therefore, captured the overall intraindividual changes from baseline to post-
treatment and allowed interindividual differences in the trajectories of change in hope. The 
variances of the intercept and slope factors were freely estimated. This approach to model 
specification did not impose a specific non-linear trajectory, but did allow for non-linear change 
trajectories as determined by the data. This analytic approach was chosen to allow us to examine 
how treatments differed in predicting the overall trajectories of change in hope across the course 
of treatment and how those trajectories of change in hope covaried with the trajectories of 
change in anxiety symptoms across the course of treatment. 
Model fit for the LGC analyses was evaluated using standard model fit indices: root-
mean-square error of approximation (RMSEA; Steiger, 1990), the Tucker–Lewis index (TLI; 
Tucker & Lewis, 1973), the comparative fit index (CFI; Bentler, 1990), and the standardized 
root-mean-square residual (SRMR; Jöreskog & Sörbom, 1996). Acceptable model fit was 
evaluated using standard model fit criteria: RMSEA and SRMR values close to 0.08 or below, 
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and CFI and TLI values close to .95 or above (Hu & Bentler, 1998). 
Results 
Does Hope Change as a function of CBT? 
 Our first analyses involve calculated means and intraindividual effect sizes to 
characterize changes in hope within and across treatment conditions. These calculations were 
conducted for the UP condition, for the four disorder specific CBT conditions collapsed (SDP), 
for the overall CBT treatment sample (UP and SDP), and for the waitlist condition. The means of 
hope (with 95% confidence intervals) and the intraindividual effect sizes by condition across 
time are reported in Table 1. As expected, results indicated that both disorder specific and 
transdiagnostic CBT resulted in increases in hope that were statistically significant and moderate 
to large in effect size magnitude. Based on the confidence intervals of the effect sizes, the 
changes in hope in CBT conditions were statistically greater than changes in the waitlist 
condition. Increases in hope were largely maintained in each active treatment condition at the six 
month follow-up assessment. Levels of hope at the follow-up were statistically significantly 
greater than baseline levels in each condition. 
When does Hope Change in CBT? 
 We next examined the magnitude of the effect size changes in each condition to 
understand when changes in hope occurred in CBT and the waitlist condition. As expected, in 
each CBT condition there was a small effect size (ESsg ~ .20) increase in hope early in treatment 
from the baseline assessment to the fourth week of treatment. Although session by session 
changes in hope were not assessed, these results indicate that hope began to demonstrably 
increase in participants early in treatment prior to when the majority of symptom change 
occurred (Barlow et al., 2017), which is consistent with the premise that hope may be a  
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transdiagnostic mechanism that helps promote subsequent changes in anxiety symptoms during 
treatment.  In contrast, the change in hope from baseline to week four of the waitlist condition 
was negligible and not statistically significant. Changes in hope in the waitlist condition were 
only present starting during the final four weeks before the post-waitlist assessment, which may 
reflect the fact that participants knew that they would begin CBT immediately following the 
completion of the waitlist condition.  
Does Hope Change consistently across CBT protocols and diagnoses? 
 We next examined how changes in hope varied across CBT conditions and principal 
diagnoses to help understand the extent to which changes in hope may be consistent across the 
treatment of anxiety. The small early increases in hope were consistent across both 
transdiagnostic and disorder specific CBT protocols, and the overall moderate to large effect size 
increase in hope was also consistent across both transdiagnostic and disorder specific CBT 
protocols. The magnitude of changes in hope was generally similar when breaking out by 
treatment condition more specifically: UP ESsg = .58 (95% CI .38 : .78); MAP ESsg = .56 (95% 
CI .08 : 1.04); MAW ESsg = .60 (95% CI .12 : 1.08); MSA ESsg = .97 (95% CI .51 : 1.43);  
MOCD ESsg = .55 (95% CI .05 : 1.04). The magnitude of changes in hope was also generally 
similar when examining changes in hope across the four anxiety disorders examined: panic 
disorder ESsg = .64 (95% CI .32: 0.96); generalized anxiety disorder ESsg = .55 (95% CI .27 : 
.83); social phobia ESsg = .82 (95% CI .50 : 1.13); obsessive compulsive disorder ESsg = .49 
(95% CI .21 : .78). For all CBT conditions and principal diagnoses, the overall changes in hope 
were moderate to large in effect size magnitude and statistically significant.  
Trajectories of Change in Hope 
 A series of LGC models was specified next to examine the overall trajectories of change 
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in hope, how changes in hope varied as a function of treatment, and how changes in hope related 
to changes in anxiety. First, an unconditional model was specified to characterize change just in 
the participants in active treatment.  The model fit statistics for this model were mostly good: (χ2 
(df = 7) = 26.7, p > .05, RMSEA = 0.12, TLI = .97, CFI = .95; SRMR = .08). The intercept (M = 
27.97; SE = .65) and slope (M = 5.73; SE .82) were both statistically significant and indicated 
that hope generally increased across the course of treatment. The slope loadings, which can be 
roughly interpreted as the proportion of change that has occurred by a given assessment point, 
were 0 (baseline), .32 (session 4), .57 (session 8), .71 (session 12), and 1.0 (post-treatment). 
These results indicate that changes in hope were occurring across all phases of treatment, but that 
the majority of change occurred in the first half of treatment. 
A conditional LGC model was then specified with a dummy coded variable representing 
treatment (0 = waitlist; 1 = CBT treatment) predicting the slope factor for hope. The model fit 
statistics for this LGC were generally good (χ2 (df = 12) = 68.65, p > .05, RMSEA = 0.10, TLI = 
.97, CFI = .96; SRMR = .07). The unstandardized effect of treatment vs waitlist on hope in this 
model was statistically significant (b = 3.54; se = 1.33; p < .05), and indicated that treatment 
resulted in greater positive changes in hope relative to waitlist. The partially standardized path 
coefficient for the effect of treatment vs waitlist on hope, which can be interpreted in the 
Cohen’s d metric, indicated that the changes in hope as a function of treatment were large in 
magnitude (β = .60, se = .22).  
A second conditional LGC model was then specified with a dummy coded variable 
representing type of treatment (0 = disorder specific CBT; 1 = transdiagnostic CBT) predicting 
the slope factor for hope. The model fit statistics for this LGC were also generally good (χ2 (df = 
12) = 33.75, p > .05, RMSEA = 0.10, TLI = .97, CFI = .96; SRMR = .10). The unstandardized 
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effect of treatment on hope in this model was not statistically significant (b = -.25; se = 1.33; p > 
.05), but indicated that transdiagnostic CBT resulted in a slightly smaller increase in hope 
relative to disorder specific CBT. The partially standardized path coefficient for the effect of 
type of treatment on hope indicated that the changes in hope as a function of transdiagnostic or 
disorder specific treatment were small in magnitude (β = -.04, se = .22). 
Associations in Change  
Two parallel process LGC were then specified to examine how trajectories of change in 
hope related to trajectories of change in anxiety in the active treatment sample through the post-
treatment assessment. First, the associations in change between hope and clinician rated anxiety 
(HAMA) were examined. The model fit (χ2 (df = 31) = 71.91, p > .05, RMSEA = 0.09, TLI = 
.95, CFI = .97; SRMR = .05) was adequate and there was a large negative association (r = -.85, 
se = .11, p <.001) between the hope and anxiety slopes, and a moderate, negative association (r = 
-.26, se = .09, p <.01) between the hope and anxiety intercepts. The associations in change 
between hope and self-reported anxiety (OASIS) were examined next. The model fit (χ2 (df = 31) 
= 87.68, p > .05, RMSEA = 0.10, TLI = .94, CFI = .96; SRMR = .06) was again adequate and 
the pattern of associations was consistent with the first parallel process model. There was a large, 
negative association (r = -.77, se = .10, p <.001) between the hope and anxiety slopes, and a 
large, negative association (r = -.53, se = .07, p <.001) between the hope and anxiety intercepts. 
The results of these parallel process models, therefore, demonstrate that higher hope is related to 
lower baseline levels of anxiety, that there is a strong relationship between changes in hope and 
changes in anxiety such that greater increases in hope are associated with greater decreases in 
anxiety, and that these relationships hold across both self-reported and clinician rated anxiety 
outcomes.  
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Two parallel process LGC were then specified to examine how trajectories of change in 
hope related to trajectories of change in anxiety in the active treatment sample through the 
follow-up assessment. First, the associations in change between hope and clinician rated anxiety 
(HAMA) were examined. The model fit (χ2 (df = 51) = 110.49, p > .05, RMSEA = 0.08, TLI = 
.95, CFI = .96; SRMR = .06) was adequate and there was a large negative association (r = -.84, 
se = .10, p <.001) between the hope and anxiety slopes, and a moderate, negative association (r = 
-.28, se = .09, p <.01) between the hope and anxiety intercepts. The associations in change 
between hope and self-reported anxiety (OASIS) were examined next. The model fit (χ2 (df = 
51) = 142.72, p > .05, RMSEA = 0.10, TLI = .92, CFI = .94; SRMR = .07) was again adequate 
and the pattern of associations was consistent with the first parallel process model. There was a 
large, negative association (r = -.75, se = .09, p <.001) between the hope and anxiety slopes, and 
a large, negative association (r = -.56, se = .07, p <.001) between the hope and anxiety intercepts. 
The relationship between changes in hope and changes anxiety therefore appears consistent 
across the acute treatment phase and through the six month follow-up assessment. 
Indirect Effects of Treatment on Anxiety via Hope 
Our final analyses examined the indirect effect of treatment on intraindividual changes in 
clinician rated and self-reported anxiety via intraindividual changes in hope. Two parallel 
process latent growth curve models were specified to examine the indirect effects of hope on 
each anxiety outcome. Figure 1 provides an example of how these models were specified. For 
both models, the slope of the anxiety outcome was regressed onto the treatment dummy code 
variable (1 = disorder specific or transdiagnostic CBT; 0 = waitlist) and the slope of hope. The 
slope of hope was regressed onto the treatment dummy code variable. The intercepts for both 
constructs were allowed to freely covary as were the slopes of each construct with the intercept 
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of that construct. The indirect effect (ab) was then calculated using the product of the effect of 
treatment on intrandividual trajectories of change in hope (a) and the effect of changes in hope 
on intrandividual trajectories of change in the anxiety disorder outcomes (b). The statistical 
significance of the indirect effect was evaluated with the product of coefficients approach by 
using the Mplus MODEL INDIRECT command. 
The results of these two models are presented in Table 2. The model fit for both models 
was acceptable. The effect of CBT treatment on hope (a) and the effects of changes in hope on 
changes in anxiety (b) was statistically significant (p < .01) and large in effect size magnitude 
based on the partially standardized and completely standardized parameter estimates, 
respectively. The indirect effect of CBT treatment on change in anxiety via changes in hope was 
also statistically significant based on the product of coefficients for both clinician rated and self-
reported anxiety. The proportion of variance (R2) explained in both the clinician rated and self-
reported anxiety was greater than .60, indicating that the combined effect of the treatment 
dummy code variable, and the slope factor of hope together predicted more than 60% of the 
variance in the changes in anxiety across the course of treatment. Additional models were 
examined in which the anxiety slope factors were only regressed on treatment to determine the 
proportion of variance that was specifically due to the inclusion of the hope slope as a predictor 
of changes in anxiety. These incremental R2 are presented in Table 2 and were large for both 
clinician rated (.41) and self-reported (.61) anxiety.  The large magnitude of these incremental 
effects underscore the importance of intraindividual changes in hope during CBT in predicting 
intraindividual changes in anxiety, and that these effects are maintained when collapsing across 
distinct CBT treatment protocols and for individuals with different principal diagnoses. 
Discussion 
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Previous research has demonstrated that CBT is an effective treatment for multiple 
anxiety and mood disorders (Hofmann, Asnaani, Bonk, Sawyer, & Fang, 2012).  Thus, there has 
increasingly been a push towards recognizing mechanisms of change in order to explain why 
CBT is effective, with the goal of refining and bolstering the effectiveness of this treatment 
modality.  Some research has focused on identifying the unique “active ingredients” promoting 
change within specific CBT modalities for particular disorders.  However, it has long been 
recognized that, while evidence does not indicate that common factors fully explain recovery 
during psychotherapy, there are core elements and processes of empirically supported treatments 
that may partially account for recovery across different treatment modalities and across a variety 
of disorders (Frank & Frank, 1991; Norcross & Wampold, in press; Snyder et al., 2000).  An 
emerging literature has indicated hope as a promising transdiagnostic mechanism of recovery, 
and the current study extends this research by examining how changes in hope influence changes 
in symptoms throughout the course of therapy, beyond simple pre- and post- treatment 
comparisons. 
The results of the present study indicate that hope increases during the course of CBT, 
and increases in hope were greater for those in active treatment than for those in the waitlist 
comparison.  The magnitude of these changes in hope were consistent across disorder specific 
CBT protocols and transdiagnostic treatment for the four anxiety disorders examined.  This is 
consistent with theories of hope as a mechanism that promotes symptom change across treatment 
modalities.  Additionally, the findings corroborate existing evidence that CBT promotes positive 
outcomes in general, reflecting greater reductions in anxiety symptoms for those in active 
treatment than for those in the waitlist comparison.   
Furthermore, the present study indicates that changes in hope are associated with changes 
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in anxiety symptoms.  The magnitude of the associations between changes in hope and changes 
in anxiety were large and suggest not only that changes in hope predict symptom recovery, but 
that hope could be a particularly important factor in predicting recovery across different 
treatment protocols.  It is important to note, however, that while these findings provide strong 
evidence that hope may be an important factor in predicting recovery across different protocols 
and diagnoses, they do not suggest that hope is the sole mechanism of recovery during CBT and 
it is likely that hope has a bidirectional influence and reinforcing effect on other coping skills and 
processes (e.g., mindfulness, cognitive reappraisal) that have previously been demonstrated to be 
important mechanisms of change during CBT for anxiety disorders. 
For those in active treatment, changes in hope started to occur within the first four 
sessions of treatment. Thus, changes in hope occurred before the majority of symptom change 
and this finding was consistent across CBT protocols and transdiagnostic treatment.  This is 
important as demonstrating temporal precedence of change is a crucial issue in identifying 
mechanisms of change (Kazdin, 2007). While some increases in hope were observed for those in 
the waitlist comparison, these changes were only significant before the final assessment point, 
and may reflect participants’ knowledge that they would begin treatment immediately following 
the waitlist condition. Although speculative, observed increases in hope in the early phase of 
treatment may help to explain the phenomenon of early rapid response in CBT participants, 
which is itself a positive prognostic indicator of post-treatment and follow-up outcome (Brady, 
Warnock-Parkes, Barker, & Ehlers, 2015). 
 Strengths of this study include the large clinical trial that allowed for the examination of 
how hope changed and related to symptom recovery across multiple diagnoses.  The current 
study measured trajectories of change throughout the course of therapy, not just during pre- and 
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post- treatment, which allows for a clearer understanding of exactly when changes in hope occur 
during CBT treatment.  The examination of changes in hope during both transdiagnostic and 
single disorder CBT protocols also provides strong evidence that increases in hope during 
treatment are not unique to any one form of CBT and provide some of the most promising 
evidence to date that promoting hope may be a transdiagnostic process in evidence based 
treatments for anxiety disorders.  It is also important to emphasize that model (i.e., CBT) unique 
and common factors are not mutually exclusive treatment elements and likely interact 
dynamically throughout a course of treatment.   
In addition, the consistent finding of an indirect effect of treatment on changes in both 
clinician rated and self-reported anxiety also strengthen conclusions regarding the role of hope as 
a potential broadly relevant mechanism in predicting anxiety as results hold across multiple 
methods of assessing intraindividual changes in symptoms during treatment. The observed 
relationships appear to be robust across different methods of assessment.  
 Although the present study provided promising evidence regarding timing and the 
consistency of changes in hope during CBT treatment, the analytic strategy and assessment 
schedule of outcomes are nevertheless important limitations in understanding temporal 
dependencies in change of hope and change in symptoms. Because outcomes were only assessed 
every four sessions, we were not able to conduct more fine-grained analyses of session by 
session changes in hope and how they may predict changes in symptoms prior to subsequent 
sessions. Quantifying session by session changes and using analytic techniques such as bivariate 
latent difference score models in future studies could strengthen conclusions regarding the causal 
role of changes in hope promoting subsequent changes in anxiety. The LGC models used in the 
present study provide strong evidence that trajectories of change in hope during treatment are 
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robustly associated with trajectories of change in anxiety symptoms, but they do not clearly 
demonstrate that early intraindividual changes in hope drive subsequent changes in anxiety. 
More research is therefore needed to establish temporal precedence of changes in hope in 
relation to anxiety during CBT, which would allow for more definitive conclusions regarding the 
role of hope as a causal mechanism of change. In the present study, our analytic approach 
initially consisted of effect sizes and the LGC analyses reported, but we also subsequently 
attempted to conduct bivariate LDS models in order to further explore bidirectional influences 
and temporal dependencies of change. Unfortunately, the bivariate LDS analyses had estimation 
issues and we were not able to obtain valid and stable results due to convergence issues so the 
results of those additional analyses are not reported.    
The present study also focuses primarily on intra-individual patterns of change in overall 
anxiety symptoms rather than changes in diagnostic status, so our findings do not speak to what 
amount of change in hope may be necessary to achieve subclinical levels of different anxiety 
disorders or complete remission of symptoms.  Other techniques such as latent growth mixture 
modeling may help elucidate how changes in hope may relate to patterns of treatment response 
(e.g. non-responders, early responders).  In addition, it may be fruitful to compare the temporal 
course of changes in the different components of hope (i.e., pathways and agency) and how these 
changes may differentially influence changes in anxiety symptoms. Given the design of the 
clinical trial we also were not able to compare the effects of treatment on hope compared to the 
waitlist condition through follow-up as waitlist participants immediately initiated treatment 
following their post-waitlist assessment and therefore did not complete a six month follow-up 
assessment.  Another important limitation is that the sample used in the present study was 
relatively homogenous in terms of race/ethnicity and education, so it will be important to 
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examine the role of hope during CBT in more diverse populations. 
Future research should also examine the role of other potential core elements or processes 
that are possibly consistent across evidence based treatments such as self-efficacy or working 
alliance quality.  Demonstrating the unique contribution of hope above and beyond other positive 
psychology constructs such as optimism or processes often examined in CBT trials such as 
expectancy and perceived control will help to clarify the specific influence of different aspects of 
positive thinking in promoting recovery during CBT. It is likely that some portion of the 
observed effects could be explained by shared variance with these other constructs. Hope and 
other core mechanisms/processes may also promote beneficial changes in other outcomes 
beyond reductions in symptoms, so examining the link between changes in hope and increases in 
well-being or other markers in positive functioning will be an important future direction. 
Overall, the findings provide supporting evidence for hope as a transdiagnostic 
mechanism that promotes positive changes in symptoms across treatment modalities.  The 
present study builds on previous research by demonstrating that changes in hope and associated 
reductions in anxiety were consistent across different CBT protocols for different disorders, as 
well as in the context of transdiagnostic treatment.  Furthermore, the findings support the role of 
hope as a mechanism of change by indicating a strong relationship between changes in hope and 
reductions in anxiety and that changes in hope partially mediate the effects of treatment on 
symptom recovery. Thus, our findings speak to the importance of how hope and other core 
processes may improve our understanding of how patients recover from anxiety disorders during 
empirically supported treatments.  
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Table 1 
Means and Intraindividual effect sizes (ESsg) of changes of Hope (with 95% confidence intervals) by condition across time 
M (95%CI) 
Timeframe CBT (n=179) UP (n=88) SDP (n=91) WL (n=44) 
Baseline 28.09 (26.82 : 29.36) 29.39 (27.51 : 31.27) 26.83 (25.15 : 28.51) 28.45 (26.00 : 30.90) 
Session 4 29.87 (28.61 : 31.14) 31.11 (29.33 : 32.90) 28.68 (26.91 : 30.44) 28.94 (26.44 : 31.45) 
Session 8 31.06 (29.75 : 32.36) 31.65 (29.80 : 33.51) 30.48 (28.65 : 32.31) 28.62 (26.08 : 31.16) 
Session 12 32.02 (30.53 : 33.50) 32.80 (30.74 : 34.86) 31.26 (29.14 : 33.37) 29.50 (26.75 : 32.26) 
Post Treatment 33.96 (32.59 : 35.33) 34.76 (32.78 : 36.75) 33.18 (31.30 : 35.06) 30.78 (28.02 : 33.54) 
6 month follow-up 32.69 (31.21 : 34.16) 33.45 (31.29 : 35.60) 31.96 (29.96 : 33.96)  
ESsg (95% CI) 
Baseline – Session 4 0.21 (0.10 : 0.31) 0.20 (0.05 : 0.35) 0.22 (0.08 : 0.36) 0.06 (-0.13 : 0.25) 
Baseline – Session 8 0.38 (0.26 : 0.50) 0.25 (0.10 : 0.41) 0.43 (0.24 : 0.61) 0.02 (-0.20 : 0.25) 
Baseline – Session 12 0.41 (0.28 : 0.54) 0.36 (0.19 : 0.53) 0.47 (0.27 : 0.67) 0.01 (-0.25 : 0.26) 
Baseline – Post-Treatment 0.65 (0.49 : 0.81) 0.58 (0.38 : 0.78) 0.73 (0.49 : 0.97) 0.26 (0.04 : 0.48) 
Baseline – 6 month follow-up 0.49 (0.35 : 0.62) 0.42 (0.22 : 0.61) 0.56 (0.37 : 0.75)  
Notes: CBT = combined active treatment sample; UP = Unified Protocol; SDP = Single Disorder CBT protocols; WL = Waitlist
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Table 2 
Results from parallel-process latent growth curve models examining the indirect effect of 
treatment on clinician rated (HAMA) and self-reported (OASIS) anxiety via hope 
Parameter Estimate HAMA OASIS  
CBT Treatment  Hope Slope (a)   
   Unstandardized 3.54** 3.61** 
   Standard Error 1.33 1.33 
   Partially Standardized .54** .60** 
   Completely Standardized .22** .24** 
Hope Slope  Anxiety Slope (b)   
   Unstandardized -.064*** -.37*** 
   Standard Error .012 0.06 
   Completely Standardized -.74*** -.81*** 
CBT Treatment  Anxiety Slope (c’)   
   Unstandardized -2.51* -1.88** 
   Standard Error 1.09 0.57 
   Partially Standardized -.45** -.69** 
   Completely Standardized -.18* -.27** 
Indirect Effect   
  ab -2.26* -1.33* 
  Standard error (ab) .91 .54 
Variance Explained (R2) Anxiety Slope .64 .83 
Incremental R2 of Hope Slope on Anxiety Slope .41 .61 
Model fit   
   χ2  98.12***  142.22*** 
   df 41 42 
   RMSEA 0.08 0.10 
   CFI .95 .94 
   TLI 0.97 0.93 
   SRMR .05 .08 
Note. HAMA = Hamilton Anxiety Scale; OASIS = Overall Anxiety Severity and Impairment 
Scale.   
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Figure 1. Example parallel process latent growth curve model examining the indirect effect of 
treatment on clinician rated anxiety (HAMA) via hope 
 
